Target intelligence / Profile preview

Cyclin and CBS domain divalent metal cation transport mediator 4 (CNNM4)

Target
CNNM4
Molecular classification
Transporter, Ion transporter, Magnesium transporter
01

Overview

Cyclin and CBS domain divalent metal cation transport mediator 4 (CNNM4) is a magnesium transporter predominantly expressed in the basolateral membranes of epithelial cells in the intestine and ameloblasts in teeth. It mediates the extrusion of intracellular Mg2+ in exchange for extracellular Na+, playing a central role in systemic magnesium balance and proper enamel formation. CNNM4 includes several structural domains: a transmembrane DUF21 domain, a pair of CBS (cystathionine β-synthase) regulatory domains, and a cyclic nucleotide-binding homology (CNBH) domain, all involved in Mg2+-ATP binding, protein-protein interactions, and cellular localization. Germline mutations of *CNNM4* cause Jalili syndrome—a rare autosomal recessive disorder combining amelogenesis imperfecta and retinal cone-rod dystrophy due to defective magnesium transport in dental and retinal tissues. CNNM4 may also regulate energy metabolism and is inversely linked to tumor progression in some cancer types[1][2][3][5][6]. There are currently no drugs established to directly target CNNM4.

Other names
Metal transporter CNNM4Ancient conserved domain-containing protein 4Cyclin-M4ACDP4SLC70A4KIAA1592Ancient conserved domain protein 4
02

Mechanism of action

Not established for any marketed or investigational drugs; CNNM4 primarily mediates Na+/Mg2+ exchange and is indirectly implicated in magnesium homeostasis and possibly tumor biology through energy metabolism.

03

Biological functions

Magnesium ion transmembrane transportSodium ion transmembrane transportBasolateral magnesium extrusion in epithelial tissuesMaintenance of systemic magnesium homeostasisEnamel formation (amelogenesis)Regulation of energy metabolismCalcium homeostasis (in sperm capacitation)
04

Disease associations

Inherited channelopathy (Jalili syndrome: cone-rod dystrophy and amelogenesis imperfecta)Defective intestinal magnesium absorption (hypomagnesemia)Possible tumor suppression (inverse relationship between CNNM4 expression and colon cancer malignancy)Male infertility (abnormal sperm motility due to defective Ca2+ homeostasis)
05

Safety considerations

Loss-of-function mutations can cause severe multisystem disease (Jalili syndrome)Major therapeutic challenge: targeting CNNM4 may interfere with essential magnesium homeostasis in multiple organs.
06

Interacting drugs

None currently established as directly targeting CNNM4. There are no approved drugs that specifically interact with CNNM4 in clinical use or in advanced studies, based on available literature.
07

Biomarkers

Pathogenic *CNNM4* mutation(s) are diagnostic for Jalili syndromeLow serum magnesium and defective amelogenesis are clinical biomarkers for inherited loss-of-function of CNNM4

Beyond the preview

Go deeper on Cyclin and CBS domain divalent metal cation transport mediator 4 (CNNM4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cyclin and CBS domain divalent metal cation transport mediator 4 (CNNM4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call